Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
about
Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancerThe Comparison of The Effects of Silybin and Silybin-Phosphatidylcholine on Viability and ESR Expression in Human Breast Cancer T47D Cell Line.Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation.Predicting the Drug Safety for Traditional Chinese Medicine through a Comparative Analysis of Withdrawn Drugs Using Pharmacological Network.A comparison inhibitory effects of cisplatin and MNPs-PEG-cisplatin on the adhesion capacity of bone metastatic breast cancer.Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability.Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway.RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus.Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
P2860
Q26995304-9D26F67D-FD55-4506-BDE7-9C3F2465EBA4Q34376252-0E18545D-6405-4A8A-B73B-5813ADB2D2DDQ34554669-A46AEC47-F907-4E7F-AF6E-1D87BADEC464Q35484007-9C01091A-EEF4-42E3-9FE9-72109F653B98Q36853573-76BD58AB-C6B3-49B5-9F9C-66432D7F33EEQ38710800-E22D7C37-A0B0-4192-9DC1-3A204BF81316Q38737031-783ECC3C-08A8-48DA-A9EA-C20CAE6FB7F9Q38858006-13CFEC5B-11A3-48FC-B218-D09C4A3C4E0EQ38934412-70059142-5B34-4805-B79C-6F04E8B84464Q47282727-50E1B6BD-63E8-4C43-9728-3A75C7FF6F79Q47726490-EB802E5B-4416-4FD5-BF91-6EA4771872CAQ48501851-D86E6864-1782-4876-844B-5B50B2C5FB3CQ49883610-0223150C-92F3-43B4-9BD3-0D52C0CBCBE5
P2860
Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@en
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@nl
type
label
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@en
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@nl
prefLabel
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@en
Inhibition of silibinin on mig ...... cules, Cdc42, Raf-1 and D4GDI.
@nl
P2860
P50
P1433
P1476
Inhibition of silibinin on mig ...... ecules, Cdc42, Raf-1 and D4GDI
@en
P2093
Nasrin Motamed
P2860
P2888
P304
P356
10.1007/S12032-011-0113-8
P50
P577
2011-11-19T00:00:00Z